Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03589326
Title	A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	Takeda
Indications	acute lymphoblastic leukemia
Therapies	Cytarabine + Methotrexate + Ponatinib Dexamethasone + Ponatinib + Vincristine Sulfate Ponatinib + Prednisone + Vincristine Sulfate Dexamethasone + Imatinib + Vincristine Sulfate Cytarabine + Imatinib + Methotrexate Imatinib + Prednisone + Vincristine Sulfate
Age Groups:	senior \| adult
Covered Countries	USA \| TUR \| POL \| ITA \| GRC \| FRA \| FIN \| ESP \| CAN \| BRA \| BGR \| AUT \| AUS \| ARG